The FDA has granted over-the-counter approval to Brytly (apraclonidine ophthalmic solution 0.125%) for the symptomatic relief ...

The newly approved autoinjector provides an alternative to the prefilled syringe for daily self-administration.

Immediate symptomatic relief and long-term neuroimmunomodulation seen with acupressure combined with pharmacotherapy ...

A nationwide voluntary recall has been issued for 22 lots of Argatroban Injection due to the presence of multi-material particulate contamination, posing potential life-threatening risks.

Vanda Pharmaceuticals has paused the clinical program for VQW-765 after a phase 3 trial evaluating the drug for social anxiety disorder failed to show significant distress reduction compared with ...

The expansion marks the first therapy approved for patients with BCG-unresponsive non-muscle-invasive bladder cancer presenting with papillary-only disease.

HealthDay News — Quadrivalent human papillomavirus (HPV) vaccination before pregnancy is associated with a lower risk for adverse pregnancy outcomes, including preterm birth, according to a study ...

HealthDay News — The amylin-based analog petrelintide achieves meaningful weight reduction for adults with obesity, according to a study published online September 29 in The Lancet Diabetes & ...

Guidelines present first-, second-, and third-line treatments and emphasize use of an informed decision-making approach ...

HealthDay News — Updated recommendations are presented for the management of urinary tract infections (UTIs) in infants and children younger than 5 years in a clinical practice guideline (CPG) issued ...

Real-world GPP data show low uptake of targeted IL-36 inhibitors and persistent reliance on corticosteroids and non-GPP ...

BRAVE-AA-PEDS data presented at FC26 show baricitinib maintained significant hair regrowth through 76 weeks in adolescents with severe alopecia areata.